Symbols / THAR $4.74 +5.80% Canton Strategic Holdings Inc
THAR Chart
About
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 187.37M |
| Enterprise Value | 166.06M | Income | -10.32M | Sales | — |
| Book/sh | 0.85 | Cash/sh | 0.22 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2 | IPO | Jan 12, 2022 |
| P/E | — | Forward P/E | -39.50 | PEG | — |
| P/S | — | P/B | 5.55 | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | 4.93 |
| Current Ratio | 4.99 | Debt/Eq | 3.18 | LT Debt/Eq | — |
| EPS (ttm) | -3.68 | EPS next Y | -0.12 | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -99.79% |
| ROE | -225.01% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 39.53M |
| Shs Float | 28.90M | Short Float | 6.72% | Short Ratio | 2.48 |
| Short Interest | — | 52W High | 9.08 | 52W Low | 0.95 |
| Beta | 1.45 | Avg Volume | 807.76K | Volume | 622.70K |
| Target Price | — | Recom | None | Prev Close | $4.48 |
| Price | $4.74 | Change | 5.80% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$4.74
Latest analyst target
3. DCF / Fair value
$-2.48
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.74
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-12-06 | init | Rodman & Renshaw | — → Buy | $17 |
- Biotech-blockchain hybrid Tharimmune prices $55M offering - Stock Titan ue, 20 Jan 2026 08
- Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy - Yahoo Finance UK Mon, 03 Nov 2025 08
- Tharimmune stock soars after $540 million private placement for Canton Coin - Investing.com Mon, 03 Nov 2025 08
- Tharimmune Decline Means Insider Profits Down To US$83k - simplywall.st hu, 23 Oct 2025 07
- Why Tharimmune (THAR) Stock Exploded This Week - TipRanks Sat, 23 Aug 2025 07
- Tharimmune And The Canton Network: A Privacy Focused, Asymmetric Bet On Tokenization - seekingalpha.com Fri, 23 Jan 2026 08
- THAR Price Today: Tharimmune, Inc. Stock Price, Quote & Chart | MEXC - MEXC hu, 29 Jan 2026 13
- Tharimmune raises $540 million from ARK Invest, DRW, Kraken and others to build Canton Coin treasury - The Block Mon, 03 Nov 2025 08
- Ex-CFTC regulator joins Tharimmune board amid blockchain finance shift - Stock Titan Mon, 02 Feb 2026 08
- Tharimmune raises $540 million from ARK Invest, DRW, Kraken and others to build Canton Coin treasury - TradingView Mon, 03 Nov 2025 08
- Tharimmune, Inc. will Change its Ticker to CNTN from THAR - marketscreener.com ue, 17 Feb 2026 08
- Tharimmune Shareholders Approve Directors, Warrant-Linked Share Issuances and 7M Share Plan Boost - Yahoo Finance Fri, 30 Jan 2026 08
- Biotech and blockchain player Tharimmune raises $55M for Canton strategy - Stock Titan hu, 22 Jan 2026 08
- Tharimmune Conducts Private Placement Offerings - TipRanks Wed, 05 Nov 2025 08
- Tharimmune (THUR) Tumbles 20.7% on $5-Million Share Sale - Yahoo Finance Wed, 27 Aug 2025 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
20.11
+61.71%
|
12.43
+31.50%
|
9.46
+37.39%
|
6.88
|
| Research And Development |
|
3.07
-51.91%
|
6.39
+79.57%
|
3.56
+56.23%
|
2.28
|
| Selling General And Administration |
|
17.03
+181.91%
|
6.04
+2.48%
|
5.90
+28.07%
|
4.60
|
| General And Administrative Expense |
|
17.03
+181.91%
|
6.04
+2.48%
|
5.90
+28.07%
|
4.60
|
| Other Gand A |
|
17.03
+181.91%
|
6.04
+2.48%
|
5.90
+28.07%
|
4.60
|
| Total Expenses |
|
20.11
+61.71%
|
12.43
+31.50%
|
9.46
+37.39%
|
6.88
|
| Operating Income |
|
-20.11
-61.71%
|
-12.43
-31.50%
|
-9.46
-37.39%
|
-6.88
|
| Total Operating Income As Reported |
|
-20.11
-61.71%
|
-12.43
-31.50%
|
-9.46
-37.39%
|
-6.88
|
| EBITDA |
|
-42.08
-245.33%
|
-12.18
-30.97%
|
-9.30
-35.17%
|
-6.88
|
| Normalized EBITDA |
|
-42.08
-245.33%
|
-12.18
-30.97%
|
-9.30
-35.17%
|
-6.88
|
| EBIT |
|
-42.08
-245.33%
|
-12.18
-30.97%
|
-9.30
-35.17%
|
-6.88
|
| Total Unusual Items |
|
—
|
—
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
—
|
—
|
| Special Income Charges |
|
—
|
—
|
—
|
—
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
—
|
—
|
| Net Income |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Pretax Income |
|
-42.10
-245.18%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Net Non Operating Interest Income Expense |
|
0.01
-94.47%
|
0.24
+73.53%
|
0.14
+108.55%
|
-1.59
|
| Interest Expense Non Operating |
|
0.03
+107.14%
|
0.01
-17.09%
|
0.02
-98.96%
|
1.59
|
| Net Interest Income |
|
0.01
-94.47%
|
0.24
+73.53%
|
0.14
+108.55%
|
-1.59
|
| Interest Expense |
|
0.03
+107.14%
|
0.01
-17.09%
|
0.02
-98.96%
|
1.59
|
| Interest Income Non Operating |
|
0.04
-83.43%
|
0.25
+63.73%
|
0.15
|
0.00
|
| Interest Income |
|
0.04
-83.43%
|
0.25
+63.73%
|
0.15
|
0.00
|
| Other Income Expense |
|
-22.01
|
—
|
—
|
—
|
| Other Non Operating Income Expenses |
|
-22.01
|
—
|
—
|
—
|
| Tax Provision |
|
-6.19
|
0.00
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Net Income From Continuing Operation Net Minority Interest |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Net Income From Continuing And Discontinued Operation |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Net Income Continuous Operations |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Normalized Income |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Net Income Common Stockholders |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Diluted EPS |
|
-1.12
+88.10%
|
-9.41
+91.21%
|
-107.02
+61.89%
|
-280.80
|
| Basic EPS |
|
-1.12
+88.10%
|
-9.41
+91.21%
|
-107.02
+61.89%
|
-280.80
|
| Basic Average Shares |
|
32.05
+2372.39%
|
1.30
+1388.64%
|
0.09
+188.54%
|
0.03
|
| Diluted Average Shares |
|
32.05
+2372.39%
|
1.30
+1388.64%
|
0.09
+188.54%
|
0.03
|
| Diluted NI Availto Com Stockholders |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
519.15
+13849.46%
|
3.72
-66.00%
|
10.95
+63.66%
|
6.69
|
| Current Assets |
|
17.39
+367.16%
|
3.72
-66.00%
|
10.95
+63.66%
|
6.69
|
| Cash Cash Equivalents And Short Term Investments |
|
17.03
+378.53%
|
3.56
-67.45%
|
10.94
+67.96%
|
6.51
|
| Cash And Cash Equivalents |
|
17.03
+378.53%
|
3.56
-67.45%
|
10.94
+67.96%
|
6.51
|
| Cash Financial |
|
17.03
+378.53%
|
3.56
-67.45%
|
10.94
+67.96%
|
6.51
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Current Deferred Assets |
|
0.00
-100.00%
|
0.12
|
0.00
|
0.00
|
| Other Current Assets |
|
0.35
+680.59%
|
0.05
+309.95%
|
0.01
-93.80%
|
0.18
|
| Total Non Current Assets |
|
501.76
|
0.00
|
0.00
|
0.00
|
| Goodwill And Other Intangible Assets |
|
501.76
|
0.00
|
—
|
—
|
| Other Intangible Assets |
|
501.76
|
—
|
—
|
—
|
| Total Liabilities Net Minority Interest |
|
121.22
+4921.60%
|
2.41
+33.00%
|
1.82
+58.52%
|
1.14
|
| Current Liabilities |
|
3.29
+36.14%
|
2.41
+33.00%
|
1.82
+58.52%
|
1.14
|
| Payables And Accrued Expenses |
|
3.29
+36.14%
|
2.41
+33.00%
|
1.82
+58.52%
|
1.14
|
| Payables |
|
1.09
+0.06%
|
1.09
+19.93%
|
0.91
-4.81%
|
0.95
|
| Accounts Payable |
|
1.09
+0.06%
|
1.09
+19.93%
|
0.91
-4.81%
|
0.95
|
| Current Accrued Expenses |
|
2.20
+65.83%
|
1.32
+46.10%
|
0.91
+375.92%
|
0.19
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
—
|
—
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Other Current Liabilities |
|
—
|
—
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
117.93
|
0.00
|
0.00
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
—
|
—
|
| Long Term Debt |
|
—
|
—
|
—
|
—
|
| Non Current Deferred Liabilities |
|
117.93
|
0.00
|
—
|
—
|
| Non Current Deferred Taxes Liabilities |
|
117.93
|
0.00
|
—
|
—
|
| Stockholders Equity |
|
397.93
+30330.80%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Common Stock Equity |
|
397.93
+30330.80%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Capital Stock |
|
0.00
+1774.24%
|
0.00
+122.47%
|
0.00
+93.48%
|
0.00
|
| Common Stock |
|
0.00
+1774.24%
|
0.00
+122.47%
|
0.00
+93.48%
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
37.39
+1793.94%
|
1.97
+152.14%
|
0.78
+2429.85%
|
0.03
|
| Ordinary Shares Number |
|
37.39
+1794.16%
|
1.97
+152.19%
|
0.78
+2449.00%
|
0.03
|
| Treasury Shares Number |
|
0.00
+0.00%
|
0.00
+1.65%
|
0.00
+0.00%
|
0.00
|
| Additional Paid In Capital |
|
470.81
+1129.96%
|
38.28
+12.90%
|
33.90
+61.47%
|
21.00
|
| Retained Earnings |
|
-72.82
-97.33%
|
-36.90
-49.38%
|
-24.70
-60.57%
|
-15.38
|
| Treasury Stock |
|
0.07
+0.00%
|
0.07
+0.00%
|
0.07
+0.00%
|
0.07
|
| Total Equity Gross Minority Interest |
|
397.93
+30330.80%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Total Capitalization |
|
397.93
+30330.80%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Working Capital |
|
14.10
+978.25%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Invested Capital |
|
397.93
+30330.80%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Total Debt |
|
—
|
—
|
—
|
—
|
| Net Debt |
|
—
|
—
|
—
|
—
|
| Net Tangible Assets |
|
-103.83
-8040.59%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Tangible Book Value |
|
-103.83
-8040.59%
|
1.31
-85.68%
|
9.13
+64.72%
|
5.54
|
| Dueto Related Parties Current |
|
—
|
—
|
—
|
0.00
|
| Interest Payable |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-16.13
-47.94%
|
-10.90
-49.34%
|
-7.30
-11.32%
|
-6.56
|
| Cash Flow From Continuing Operating Activities |
|
-16.13
-47.94%
|
-10.90
-49.34%
|
-7.30
-11.32%
|
-6.56
|
| Net Income From Continuing Operations |
|
-35.92
-194.45%
|
-12.20
-30.89%
|
-9.32
-9.98%
|
-8.47
|
| Other Non Cash Items |
|
0.10
+388.67%
|
0.02
-94.13%
|
0.35
-79.21%
|
1.68
|
| Stock Based Compensation |
|
2.88
+305.15%
|
0.71
-14.61%
|
0.83
+3.89%
|
0.80
|
| Deferred Tax |
|
-6.19
|
0.00
|
—
|
—
|
| Deferred Income Tax |
|
-6.19
|
0.00
|
—
|
—
|
| Operating Gains Losses |
|
22.01
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
22.01
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
0.99
+74.67%
|
0.56
-32.54%
|
0.84
+247.09%
|
-0.57
|
| Change In Prepaid Assets |
|
-0.31
-800.17%
|
-0.03
-120.49%
|
0.17
+255.51%
|
-0.11
|
| Change In Payables And Accrued Expense |
|
1.29
+116.13%
|
0.60
-10.62%
|
0.67
+245.14%
|
-0.46
|
| Change In Accrued Expense |
|
1.07
+156.55%
|
0.42
-41.64%
|
0.72
+694.10%
|
-0.12
|
| Change In Payable |
|
0.22
+22.86%
|
0.18
+494.29%
|
-0.05
+86.54%
|
-0.34
|
| Change In Account Payable |
|
0.22
+22.86%
|
0.18
+494.29%
|
-0.05
+67.47%
|
-0.14
|
| Investing Cash Flow |
|
-77.57
|
0.00
|
0.00
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
-77.57
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
-77.57
|
—
|
—
|
—
|
| Net Intangibles Purchase And Sale |
|
-77.57
|
0.00
|
—
|
—
|
| Purchase Of Intangibles |
|
-77.57
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
107.17
+2939.54%
|
3.53
-69.93%
|
11.72
-10.25%
|
13.06
|
| Cash Flow From Continuing Financing Activities |
|
107.17
+2939.54%
|
3.53
-69.93%
|
11.72
-10.25%
|
13.06
|
| Net Issuance Payments Of Debt |
|
-0.22
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Issuance Of Debt |
|
—
|
—
|
0.00
-100.00%
|
0.12
|
| Repayment Of Debt |
|
-0.22
|
0.00
|
0.00
+100.00%
|
-0.14
|
| Long Term Debt Issuance |
|
—
|
—
|
0.00
-100.00%
|
0.12
|
| Long Term Debt Payments |
|
-0.22
|
0.00
|
0.00
+100.00%
|
-0.14
|
| Net Long Term Debt Issuance |
|
-0.22
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Net Common Stock Issuance |
|
115.67
+2662.19%
|
4.19
-65.77%
|
12.23
-9.88%
|
13.58
|
| Common Stock Payments |
|
—
|
—
|
0.00
+100.00%
|
-0.07
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
+100.00%
|
-0.07
|
| Proceeds From Stock Option Exercised |
|
1.71
|
0.00
-100.00%
|
0.01
-62.38%
|
0.02
|
| Net Other Financing Charges |
|
-9.98
-1408.44%
|
-0.66
-27.46%
|
-0.52
+0.41%
|
-0.52
|
| Changes In Cash |
|
13.47
+282.67%
|
-7.38
-266.70%
|
4.42
-31.99%
|
6.51
|
| Beginning Cash Position |
|
3.56
-67.45%
|
10.94
+67.96%
|
6.51
+149361.29%
|
0.00
|
| End Cash Position |
|
17.03
+378.53%
|
3.56
-67.45%
|
10.94
+67.96%
|
6.51
|
| Free Cash Flow |
|
-93.70
-759.48%
|
-10.90
-49.34%
|
-7.30
-11.32%
|
-6.56
|
| Interest Paid Supplemental Data |
|
0.03
+107.14%
|
0.01
-17.09%
|
0.02
-25.79%
|
0.02
|
| Change In Interest Payable |
|
—
|
—
|
0.00
-100.00%
|
0.01
|
| Common Stock Issuance |
|
115.67
+2662.19%
|
4.19
-65.77%
|
12.23
-10.34%
|
13.65
|
| Issuance Of Capital Stock |
|
115.67
+2662.19%
|
4.19
-65.77%
|
12.23
-10.34%
|
13.65
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|